Director Montgomery Reports a $504,000 $EPD Purchase

Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.

Here's what stood out today:

📌 Enterprise Products $EPD – Director William Montgomery just grabbed $504,000 worth of shares.

That’s two insider buys in two days at EPD. Energy execs aren’t shy about showing conviction here.

📌 NovoCure $NVCR – CFO Christoph Brackmann just dropped $232,000 on shares.

This insider buy comes on the heels of an over 30% drop in less than a week. 

Here’s The Hot Corner, with data from July 30, 2025:

Click the table to enlarge it.

📌 Tilray $TLRY – CEO Irwin Simon and CFO  Carl Merton stepped in with buys totaling $100,000.

Cannabis has been a graveyard lately. But this could be the shot in the arm TLRY needs.

📌 Cidara Therapeutics $CDTX – Paradigm Biocapital filed a 13G, disclosing a 5.60% stake.

But smart money is clearly showing interest here as the stock attempts a massive trend reversal.